• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种在存在抗体依赖性增强作用的情况下优化疫苗接种覆盖率以减少媒介传播感染的概念模型。

A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.

作者信息

Tang Biao, Huo Xi, Xiao Yanni, Ruan Shigui, Wu Jianhong

机构信息

School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China.

Centre for Disease Modelling, Laboratory for Industrial and Applied Mathematics, York University, Toronto, M3J 1P3, Canada.

出版信息

Theor Biol Med Model. 2018 Sep 3;15(1):13. doi: 10.1186/s12976-018-0085-x.

DOI:10.1186/s12976-018-0085-x
PMID:30173664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6120075/
Abstract

BACKGROUND

Many vector-borne diseases co-circulate, as the viruses from the same family are also transmitted by the same vector species. For example, Zika and dengue viruses belong to the same Flavivirus family and are primarily transmitted by a common mosquito species Aedes aegypti. Zika outbreaks have also commonly occurred in dengue-endemic areas, and co-circulation and co-infection of both viruses have been reported. As recent immunological cross-reactivity studies have confirmed that convalescent plasma following dengue infection can enhance Zika infection, and as global efforts of developing dengue and Zika vaccines are intensified, it is important to examine whether and how vaccination against one disease in a large population may affect infection dynamics of another disease due to antibody-dependent enhancement.

METHODS

Through a conceptual co-infection dynamics model parametrized by reported dengue and Zika epidemic and immunological cross-reactivity characteristics, we evaluate impact of a hypothetical dengue vaccination program on Zika infection dynamics in a single season when only one particular dengue serotype is involved.

RESULTS

We show that an appropriately designed and optimized dengue vaccination program can not only help control the dengue spread but also, counter-intuitively, reduce Zika infections. We identify optimal dengue vaccination coverages for controlling dengue and simultaneously reducing Zika infections, as well as the critical coverages exceeding which dengue vaccination will increase Zika infections.

CONCLUSION

This study based on a conceptual model shows the promise of an integrative vector-borne disease control strategy involving optimal vaccination programs, in regions where different viruses or different serotypes of the same virus co-circulate, and convalescent plasma following infection from one virus (serotype) can enhance infection against another virus (serotype). The conceptual model provides a first step towards well-designed regional and global vector-borne disease immunization programs.

摘要

背景

许多媒介传播疾病共同流行,因为同一家族的病毒也由同一媒介物种传播。例如,寨卡病毒和登革热病毒属于同一黄病毒科,主要由常见的埃及伊蚊传播。寨卡疫情也经常在登革热流行地区发生,并且两种病毒的共同流行和共同感染已有报道。由于最近的免疫交叉反应研究证实,登革热感染后的康复期血浆可增强寨卡病毒感染,并且随着全球开发登革热和寨卡疫苗的努力不断加强,重要的是要研究在大量人群中针对一种疾病进行疫苗接种是否以及如何因抗体依赖性增强而影响另一种疾病的感染动态。

方法

通过一个由报道的登革热和寨卡疫情及免疫交叉反应特征参数化的概念性共同感染动态模型,我们评估了一个假设的登革热疫苗接种计划在仅涉及一种特定登革热血清型的单个季节对寨卡病毒感染动态的影响。

结果

我们表明,精心设计和优化的登革热疫苗接种计划不仅有助于控制登革热传播,而且与直觉相反,还能减少寨卡病毒感染。我们确定了控制登革热并同时减少寨卡病毒感染的最佳登革热疫苗接种覆盖率,以及超过该覆盖率登革热疫苗接种将增加寨卡病毒感染的临界覆盖率。

结论

这项基于概念模型的研究表明,在不同病毒或同一病毒的不同血清型共同流行且一种病毒(血清型)感染后的康复期血浆可增强对另一种病毒(血清型)感染的地区,采用涉及最佳疫苗接种计划的综合媒介传播疾病控制策略具有前景。该概念模型为精心设计的区域和全球媒介传播疾病免疫计划迈出了第一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/e755c181dff9/12976_2018_85_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/f1770ce2c05e/12976_2018_85_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/0c84a2a6fa38/12976_2018_85_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/d7803f0a351e/12976_2018_85_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/54838f7857f7/12976_2018_85_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/6e27d09f5785/12976_2018_85_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/eb60696bdd7b/12976_2018_85_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/c49300e58009/12976_2018_85_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/657babe49bb8/12976_2018_85_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/f624b761eb8c/12976_2018_85_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/e755c181dff9/12976_2018_85_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/f1770ce2c05e/12976_2018_85_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/0c84a2a6fa38/12976_2018_85_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/d7803f0a351e/12976_2018_85_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/54838f7857f7/12976_2018_85_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/6e27d09f5785/12976_2018_85_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/eb60696bdd7b/12976_2018_85_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/c49300e58009/12976_2018_85_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/657babe49bb8/12976_2018_85_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/f624b761eb8c/12976_2018_85_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a03/6120075/e755c181dff9/12976_2018_85_Fig10_HTML.jpg

相似文献

1
A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.一种在存在抗体依赖性增强作用的情况下优化疫苗接种覆盖率以减少媒介传播感染的概念模型。
Theor Biol Med Model. 2018 Sep 3;15(1):13. doi: 10.1186/s12976-018-0085-x.
2
Current concerns and perspectives on Zika virus co-infection with arboviruses and HIV.寨卡病毒与虫媒病毒和 HIV 合并感染的当前关注和观点。
J Autoimmun. 2018 May;89:11-20. doi: 10.1016/j.jaut.2018.01.002. Epub 2018 Jan 17.
3
Implication of sexual transmission of Zika on dengue and Zika outbreaks.寨卡病毒性传播对登革热和寨卡疫情的影响。
Math Biosci Eng. 2019 Jun 3;16(5):5092-5113. doi: 10.3934/mbe.2019256.
4
Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses.登革热病毒和寨卡病毒:从这些由伊蚊传播的虫媒病毒的相似性中汲取的教训。
J Microbiol. 2017 Feb;55(2):81-89. doi: 10.1007/s12275-017-6494-4. Epub 2017 Jan 26.
5
Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine.黄病毒属 Zika 病毒 DNA 疫苗在小鼠中对四型登革热病毒的交叉保护作用。
Front Cell Infect Microbiol. 2019 May 8;9:147. doi: 10.3389/fcimb.2019.00147. eCollection 2019.
6
Dengue Antibody and Zika: Friend or Foe?登革热抗体与寨卡病毒:是敌是友?
Trends Immunol. 2016 Oct;37(10):635-636. doi: 10.1016/j.it.2016.08.006. Epub 2016 Sep 3.
7
Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission.四价登革热疫苗结合筛查、抗体依赖增强作用及感染性改变对单血清型登革热和寨卡病毒传播的影响
J Math Biol. 2023 Apr 29;86(5):85. doi: 10.1007/s00285-023-01915-7.
8
[Dengue, zika, chikungunya and the development of vaccines].[登革热、寨卡病毒、基孔肯雅热与疫苗的研发]
Medicina (B Aires). 2018;78(1):23-28.
9
The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil.登革热、寨卡和基孔肯雅热对巴西构成的挑战。
Front Immunol. 2018 Aug 28;9:1964. doi: 10.3389/fimmu.2018.01964. eCollection 2018.
10
Optimal control of vaccination in a vector-borne reaction-diffusion model applied to Zika virus.应用于寨卡病毒的媒介传播反应扩散模型中疫苗接种的最优控制
J Math Biol. 2019 Aug;79(3):1077-1104. doi: 10.1007/s00285-019-01390-z. Epub 2019 Jun 11.

引用本文的文献

1
Exploring Zika's dynamics: A scoping review journey from epidemic to equations through mathematical modelling.探索寨卡病毒的动态:从疫情到通过数学建模构建方程的范围综述之旅。
Infect Dis Model. 2024 Dec 31;10(2):536-558. doi: 10.1016/j.idm.2024.12.016. eCollection 2025 Jun.
2
The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age.新型冠状病毒病(COVID-19)所致死亡率的年龄分布提示,年龄对易感性无明显差异。
Sci Rep. 2020 Oct 6;10(1):16642. doi: 10.1038/s41598-020-73777-8.
3
Modelling the impact of antibody-dependent enhancement on disease severity of Zika virus and dengue virus sequential and co-infection.

本文引用的文献

1
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.既往抗黄病毒免疫增强寨卡病毒致病性
Science. 2017 Apr 14;356(6334):175-180. doi: 10.1126/science.aal4365. Epub 2017 Mar 30.
2
Zika in Rio de Janeiro: Assessment of basic reproduction number and comparison with dengue outbreaks.里约热内卢的寨卡病毒:基本繁殖数评估及与登革热疫情的比较
Epidemiol Infect. 2017 Jun;145(8):1649-1657. doi: 10.1017/S0950268817000358. Epub 2017 Feb 27.
3
Prevention and control of dengue-the light at the end of the tunnel.
模拟抗体依赖增强对寨卡病毒和登革病毒序贯感染及共感染疾病严重程度的影响。
R Soc Open Sci. 2020 Apr 15;7(4):191749. doi: 10.1098/rsos.191749. eCollection 2020 Apr.
登革热的预防与控制——隧道尽头的亮光。
Lancet Infect Dis. 2017 Mar;17(3):e79-e87. doi: 10.1016/S1473-3099(16)30471-6. Epub 2017 Feb 7.
4
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.重组减毒活登革热疫苗(登革四价疫苗)常规接种的长期安全性、对公众健康的影响及成本效益:一项模型比较研究
PLoS Med. 2016 Nov 29;13(11):e1002181. doi: 10.1371/journal.pmed.1002181. eCollection 2016 Nov.
5
Estimate of the reproduction number of the 2015 Zika virus outbreak in Barranquilla, Colombia, and estimation of the relative role of sexual transmission.2015年哥伦比亚巴兰基亚寨卡病毒疫情的繁殖数估计及性传播相对作用的评估
Epidemics. 2016 Dec;17:50-55. doi: 10.1016/j.epidem.2016.10.003. Epub 2016 Oct 17.
6
Implication of vaccination against dengue for Zika outbreak.登革热疫苗接种对寨卡疫情的影响。
Sci Rep. 2016 Oct 24;6:35623. doi: 10.1038/srep35623.
7
Zika virus epidemic: an update.寨卡病毒疫情:最新情况
Expert Rev Anti Infect Ther. 2016 Dec;14(12):1127-1138. doi: 10.1080/14787210.2016.1245614. Epub 2016 Oct 21.
8
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.赛诺菲巴斯德登革热疫苗的益处与风险:模拟优化部署
Science. 2016 Sep 2;353(6303):1033-1036. doi: 10.1126/science.aaf9590.
9
Zika Virus: Immunity and Vaccine Development.寨卡病毒:免疫与疫苗研发
Cell. 2016 Oct 20;167(3):625-631. doi: 10.1016/j.cell.2016.09.020. Epub 2016 Sep 29.
10
Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro.一种源自登革热的单克隆抗体在体外增强寨卡病毒感染方面的效用
PLoS Curr. 2016 Jul 5;8:ecurrents.outbreaks.4ab8bc87c945eb41cd8a49e127082620. doi: 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620.